Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care

DNA

A Statewide Resource

The Iowa Institute of Human Genetics (IIHG) is dedicated to promoting clinical care, research and education focused on the medical and scientific significance of variation in the human genome. The IIHG serves as a statewide resource for outreach about issues related to understanding the extent and meaning of human DNA sequence variation. Learn more...

 

Ask an Expert

Ask an Expert

Ask a member of the Iowa Institute of Human Genetics your genetics-related question. Complete this online form and we will be happy to assist you.

Events

Distinguished Biomedical Scholar Lecture - Akiko Iwasaki, PhD

Thursday, February 17, 2022, 4:00pm to 5:00pm

Dr. Akiko Iwasaki will present a lecture on February 17 at 4:00pm. Dr. Iwasaki is the Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular and Developmental Biology, Professor of Epidemiology (Microbial Diseases) at Yale University, and a Howard Hughes Medical Institute Investigator.  Presentation details will be updated closer to the event date and may be held via Zoom instead of in-person. ...

Ramon and Victoria Lim Medical Science Lecture - Yi Zhang, PhD

Thursday, April 14, 2022, 12:00pm to 1:00pm

Dr. Yi Zhang, PhD, will visit campus on April 14, 2022 to present a lecture (TBD) at 12:00pm in the Urmila Sahai Seminar Room (2117 MERF). Dr. Zhang is a Howard Hughes Medical Institute Investigator and the Fred Rosen Professor of Genetics and Pediatrics at Harvard Medical School.   This lecture is co-sponsored by the Distinguished Biomedical Scholar Lecture Series.    

Distinguished Biomedical Scholar Lecture - Sekar Kathiresan, MD

Thursday, April 21, 2022, 4:00pm to 5:00pm

Dr. Sekar Kathiresan will present a lecture on April 21 at 4:00pm. Dr. Kathiresan is Professor of Medicine in the Center for Genomic Medicine at Massachusetts General Hospital and Harvard Medical School. He is Co-Founder and CEO of Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines.  Presentation details will be updated closer to the event date and...